OPT Sciences Corp. OPST Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
OPT Sciences Corp. OPST Company Overview 

Stock Message Board http://investorshangout.com/search?q=OPST&...mp;yt1=Go!

OPT Sciences Corp. OPST Current Price and Quotes
Last Price 15.94
Previous Close 15.94 Open N/A
Daily Range N/A - N/A 52wk Range 17.00 - 13.11
Volume 0 Dividend N/A
Average Vol (3m) 564 Yield N/A
OPT Sciences Corp. OPST
Company Information

1912 Bannard Street
Cinnaminson, NJ 08077

Website: http://www.optsciences.com
Phone: (856) 829-2800
Email: investor.relations@optsciences.com

OPT Sciences Corp. OPST
Opt-Sciences through its operating subsidiary O & S Research, has been manufacturing precision optical components for the Aerospace Industry since 1950.

OPT Sciences Corp. OPST
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jul 27, 2013 10-Q
CIK 0000074688
Fiscal Year End 10/29
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 3827 - Optical instruments and lenses
Incorporated In: NJ, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Anderson McCabe President
Arthur Kania Secretary
Company Directors

Not Available
Service Providers

Auditor/Accountant
Goff Backa Alfera & Company, LLC
3325 Saw Mill Run Blvd.
Pittsburgh, PA, 15227
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

OPT Sciences Corp. OPST
OPST Security Details

Share Structure

Market Value1 $12,362,825 a/o Sep 20, 2013
Shares Outstanding 775,585 a/o Sep 10, 2013
Float Not Available
Authorized Shares Not Available
Par Value  2.05
Shareholders

Shareholders of Record 576 a/o Jan 25, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.65) Dec 06, 2012 Dec 10, 2012 Dec 21, 2012
Security Notes

New Issue=10-60 135,000 shs at $3 1/2 by M. L. Lee & Co., Inc. et al.
Short Selling Data

Short Interest 0 (-100%)
Jun 28, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Broadridge Financial Solutions, Inc.

OPT Sciences Corp. OPST Recent News

OPT Sciences Corp. OPST Financials
Period Ending Oct 27, 2012 Oct 29, 2011 Oct 30, 2010 Oct 31, 2009
Total Revenue 6,687 5,920 4,900 4,881
Cost of Revenue 4,663 3,962 3,444 3,612
Gross Profit 2,024 1,958 1,456 1,269
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 1,031 897 829 780
Non-Recurring Items - - - -
Other - - - -
Operating Income 993 1,061 627 489
Income From Continuing Operations

Add'l Income/Expense Items 493 261 75 (18)
Earnings Before Interest and Tax 1,486 1,323 702 471
Interest Expense - - - -
Earnings Before Tax 1,486 1,323 702 471
Income Tax 547 460 242 200
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 939 863 461 272
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 939 863 461 272
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 939 863 461 272

OPST OPT Sciences Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=OPST&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/OPST/quote
Stock Chart http://www.otcmarkets.com/stock/OPST/chart
Company Info http://www.otcmarkets.com/stock/OPST/company-info
Recent News http://www.otcmarkets.com/stock/OPST/news
Financials http://www.otcmarkets.com/stock/OPST/financials
Filings and Disclosure http://www.otcmarkets.com/stock/OPST/filings
Short Sales http://www.otcmarkets.com/stock/OPST/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/OPST/insider-transactions
Research Reports http://www.otcmarkets.com/stock/OPST/research
Summary http://finance.yahoo.com/q?s=OPST
Historical Prices http://finance.yahoo.com/q/hp?s=OPST+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=OPST
Basic Chart http://finance.yahoo.com/q/bc?s=OPST+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=OPST+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=OPST+Headlines
Press Releases http://finance.yahoo.com/q/p?s=OPST+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=OPST+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=OPST+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=OPST+Industry
Major Holders http://finance.yahoo.com/q/mh?s=OPST+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=OPST+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=OPST+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=OPST
Balance Sheet http://finance.yahoo.com/q/bs?s=OPST
Cash Flow http://finance.yahoo.com/q/cf?s=OPST+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/OPST
Market Watch http://www.marketwatch.com/investing/stock/OPST
Bloomberg http://www.bloomberg.com/quote/OPST:US
Morningstar http://quotes.morningstar.com/stock/s?t=OPST
Bussinessweek http://investing.businessweek.com/research/st...icker=OPST
Barchart http://www.barchart.com/quotes/stocks/OPST
OTC Short Report http://otcshortreport.com/index.php?index=OPST
Investopedia http://www.investopedia.com/markets/stocks/OPST/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 263

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 192

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 327

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 303

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 421

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 344

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
News Articles